يعرض 1 - 10 نتائج من 83 نتيجة بحث عن '"Tzankov, A"', وقت الاستعلام: 1.43s تنقيح النتائج
  1. 1
    Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

    المؤلفون: Maher Albitar, Hong Zhang, Andre Goy, Zijun Y. Xu-Monette, Govind Bhagat, Carlo Visco, Alexandar Tzankov, Xiaosheng Fang, Feng Zhu, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Fredrick B. Hagemeister, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel A. Piris, Jane N. Winter, Yong Li, Bing Xu, Ken H. Young

    المصدر: Blood Cancer Journal, Vol 12, Iss 2, Pp 1-9 (2022)
    Blood Cancer Journal, 12
    Blood Cancer Journal, 12, 2
    Albitar, M, Zhang, H, Goy, A, Xu-Monette, Z Y, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Møller, M B, Parsons, B M, van Krieken, J H, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2022, ' Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms ', Blood Cancer Journal, vol. 12, no. 2, 25 . https://doi.org/10.1038/s41408-022-00617-5Test
    Albitar, M, Zhang, H, Goy, A H, Xu-Monette, Z, Bhagat, G, Visco, C, Tzankov, A, Fang, X, Zhu, F, Dybkaer, K, Chiu, A, Tam, W, Zu, Y, Hsi, E D, Hagemeister, F B, Huh, J, Ponzoni, M, Ferreri, A J M, Moller, M, Parsons, B M, Van Krieken, J H J M, Piris, M A, Winter, J N, Li, Y, Xu, B & Young, K H 2021, ' Determining Clinical Course of Diffuse Large B-Cell Lymphoma Using Targeted Transcriptome and Machine Learning Algorithms ', Blood, vol. 138, no. Suppl. 1, 2395 . https://doi.org/10.1182/blood-2021-148841Test
    Blood Cancer Journal

    مصطلحات موضوعية: Vincristine/therapeutic use, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], Immunology, Prednisone/therapeutic use, Biochemistry, Article, Machine Learning, All institutes and research themes of the Radboud University Medical Center, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Rituximab/therapeutic use, Humans, Cyclophosphamide, RC254-282, Cancer, Lymphoma, Large B-Cell, Diffuse/diagnosis, B-cell lymphoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cell Biology, Hematology, Translational research, Prognosis, Oncology, Doxorubicin, Vincristine, Cyclophosphamide/therapeutic use, Prednisone, Doxorubicin/therapeutic use, Lymphoma, Large B-Cell, Diffuse, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Rituximab, Transcriptome, Algorithms

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c9ae5e528b2a56ac4958ad97d7f7744Test
    https://doaj.org/article/93888a803eda4609ab485bda57596d9cTest


    أضف إلى المفضلة
  2. 2
    Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy

    المؤلفون: Menter, Thomas, Tzankov, Alexandar, Zucca, Emanuele, Kimby, Eva, Hultdin, Magnus, Sundstrom, Christer, Beiske, Klaus, Cogliatti, Sergio, Banz, Yara, Cathomas, Gieri, Katjalainen-Lindsberg, Marja-Liisa, Grobholz, Rainer, Mazzucchelli, Luca, Sander, Birgitta, Hawle, Hanne, Hayoz, Stefanie, Dirnhofer, Stefan

    المصدر: British Journal of Haematology. 189(4):707-717

    مصطلحات موضوعية: follicular lymphoma, lenalidomide, rituximab, PD1, GATA3

    وصف الملف: print

    الوصول الحر: https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-168139Test


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Assessment of CD37 B-cell antigen and cell-of-origin significantly improves risk prediction in diffuse large B-cell lymphoma

    المؤلفون: Xu-Monette, ZY, Li, L, Byrd, JC, Jabbar, KJ, Manyam, GC, de Winde, CM, van den Brand, M, Tzankov, A, Visco, C, Wang, J, Dybkaer, K, Chiu, A, Orazi, A, Zu, Y, Bhagat, G, Richards, KL, Hsi, ED, Choi, WWL, Huh, J, Ponzoni, M, Ferreri, AJM, Moller, MB, Parsons, BM, Winter, JN, Wang, M, Hagemeister, FB, Piris, MA, van Krieken, JH, Medeiros, LJ, Li, Y, van Spriel, AB, Young, KH

    المصدر: Blood , 128 (26) pp. 3083-3100. (2016)

    مصطلحات موضوعية: CD37, DLBCL, M-IPI-R, PD-1, ICOSLG, COO, IPI, R-CHOP, rituximab, CD20, CTLA-4, GCB, ABC

    وصف الملف: text

    العلاقة: https://discovery.ucl.ac.uk/id/eprint/1556643/1/De%20Winde_BLOOD-2016-715094v3-Young%255B1%255D.pdfTest; https://discovery.ucl.ac.uk/id/eprint/1556643Test/

    الإتاحة: https://discovery.ucl.ac.uk/id/eprint/1556643/1/De%20Winde_BLOOD-2016-715094v3-Young%255B1%255D.pdfTest
    https://discovery.ucl.ac.uk/id/eprint/1556643Test/

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP

    المؤلفون: Xu-Monette, Zijun Y, Dabaja, Bouthaina S, Wang, Xiaoxiao, Tu, Meifeng, Manyam, Ganiraju C, Tzankov, Alexander, Xia, Yi, Zhang, Li Li, Sun, Ruifang, Visco, Carlo, Dybkaer, Karen, Yin, Lihui, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L, Hsi, Eric D, Choi, William W L, van Krieken, J Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J M, Møller, Michael B, Parsons, Ben M, Zhao, Xiaoying, Winter, Jane N, Piris, Miguel A, McDonnell, Timothy J, Miranda, Roberto N, Li, Yong, Medeiros, L Jeffrey, Young, Ken H

    المصدر: Xu-Monette , Z Y , Dabaja , B S , Wang , X , Tu , M , Manyam , G C , Tzankov , A , Xia , Y , Zhang , L L , Sun , R , Visco , C , Dybkaer , K , Yin , L , Chiu , A , Orazi , A , Zu , Y , Bhagat , G , Richards , K L , Hsi , E D , Choi , W W L , van Krieken , J H , Huh , J , Ponzoni , M , Ferreri ....

    مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Doxorubicin, Female, Gene Rearrangement, Genes, myc, Humans, Immunohistochemistry, In Situ Hybridization, Fluorescence, Kaplan-Meier Estimate, Lymphoma, Large B-Cell, Diffuse, Male, Middle Aged, Prednisone, Prognosis, Proportional Hazards Models, Proto-Oncogene Proteins c-myc, Rituximab, Transcriptome, Vincristine, Journal Article, Research Support, N.I.H., Extramural

    وصف الملف: application/pdf

    العلاقة: https://portal.findresearcher.sdu.dk/da/publications/680fbf05-14b7-42a6-8381-3dbd94d564b7Test

    الإتاحة: https://doi.org/10.1038/modpathol.2015.118Test
    https://portal.findresearcher.sdu.dk/da/publications/680fbf05-14b7-42a6-8381-3dbd94d564b7Test
    https://findresearcher.sdu.dk/ws/files/135785627/modpathol2015118.pdfTest

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Immune profiling and quantitative analysis decipher the clinical role of immune-checkpoint expression in the tumor immune microenvironment of DLBCL

    المؤلفون: Xu-Monette Z. Y., Xiao M., Au Q., Padmanabhan R., Xu B., Hoe N., Rodriguez-Perales S., Torres-Ruiz R., Manyam G. C., Visco C., Miao Y., Tan X., Zhang H., Tzankov A., Wang J., Dybkaer K., Tam W., You H., Bhagat G., Hsi E. D., Ponzoni M., Ferreri A. J. M., Moller M. B., Piris M. A., Han van Krieken J., Winter J. N., Westin J. R., Pham L. V., Jeffrey Medeiros L., Rassidakis G. Z., Li Y., Freeman G. J., Young K. H.

    المساهمون: Xu-Monette, Z. Y., Xiao, M., Au, Q., Padmanabhan, R., Xu, B., Hoe, N., Rodriguez-Perales, S., Torres-Ruiz, R., Manyam, G. C., Visco, C., Miao, Y., Tan, X., Zhang, H., Tzankov, A., Wang, J., Dybkaer, K., Tam, W., You, H., Bhagat, G., Hsi, E. D., Ponzoni, M., Ferreri, A. J. M., Moller, M. B., Piris, M. A., Han van Krieken, J., Winter, J. N., Westin, J. R., Pham, L. V., Jeffrey Medeiros, L., Rassidakis, G. Z., Li, Y., Freeman, G. J., Young, K. H.

    مصطلحات موضوعية: Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocols, B7-H1 Antigen, CTLA-4 Antigen, Cyclophosphamide, Doxorubicin, Drug Resistance, Neoplasm, Gene Expression Regulation, Neoplastic, Humans, Killer Cells, Natural, Lymphoma, Large B-Cell, Diffuse, Middle Aged, Phenotype, Prednisone, Prognosis, Programmed Cell Death 1 Receptor, Rituximab, T-Lymphocytes, Tumor Microenvironment, Vincristine

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000462983600012; volume:7; issue:4; firstpage:644; lastpage:657; numberofpages:14; journal:CANCER IMMUNOLOGY RESEARCH; http://hdl.handle.net/20.500.11768/109975Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85064144546

    الإتاحة: https://doi.org/20.500.11768/109975Test
    https://doi.org/10.1158/2326-6066.CIR-18-0439Test
    https://hdl.handle.net/20.500.11768/109975Test

    View record in BASE

    أضف إلى المفضلة
  6. 6
    Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy

    المؤلفون: M. Ponzoni, Wayne Tam, J.H.J.M. van Krieken, Lijuan Deng, Praveen Jain, Luis Fayad, Jianxiang Wang, Govind Bhagat, Ganiraju C. Manyam, Hagop M. Kantarjian, L. J. Medeiros, Y Liu, Ken H. Young, Karen Dybkær, Jorge E. Cortes, C. Visco, Yong Li, Jane N. Winter, Zhilei Yao, Robert Z. Orlowski, Anna Ferreri, Alexandar Tzankov, Zijun Y. Xu-Monette, M A Piris, Eric D. Hsi, Yongping Song, Michael Boe Møller

    المساهمون: Yao, Z., Deng, L., Xu-Monette, Z. Y., Manyam, G. C., Jain, P., Tzankov, A., Visco, C., Bhagat, G., Wang, J., Dybkaer, K., Tam, W., Hsi, E. D., Van Krieken, J. H., Ponzoni, M., Ferreri, A. J. M., Moller, M. B., Winter, J. N., Piris, M. A., Fayad, L., Liu, Y., Song, Y., Orlowski, R. Z., Kantarjian, H., Medeiros, L. J., Li, Y., Cortes, J., Young, K. H.

    المصدر: Leukemia, 32, 353-363
    Yao, Z, Deng, L, Xu-Monette, Z Y, Manyam, G C, Jain, P, Tzankov, A, Visco, C, Bhagat, G, Wang, J, Dybkaer, K, Tam, W, Hsi, E D, van Krieken, J H, Ponzoni, M, Ferreri, A J M, Møller, M B, Winter, J N, Piris, M A, Fayad, L, Liu, Y, Song, Y, Orlowski, R Z, Kantarjian, H, Medeiros, L J, Li, Y, Cortes, J & Young, K H 2018, ' Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy ', Leukemia, vol. 32, no. 2, pp. 353-363 . https://doi.org/10.1038/leu.2017.222Test
    Leukemia, 32, 2, pp. 353-363
    Yao, Z, Deng, L, Xu-Monette, Z Y, Manyam, G C, Jain, P, Tzankov, A, Visco, C, Bhagat, G, Wang, J, Dybkær, K, Tam, W, Hsi, E D, van Krieken, J H, Ponzoni, M, Ferreri, A J M, Møller, M B, Winter, J N, Piris, M A, Fayad, L, Liu, Y, Song, Y, Orlowski, R Z, Kantarjian, H, Medeiros, L J, Li, Y, Cortes, J & Young, K H 2018, ' Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy ', Leukemia, vol. 32, no. 2, pp. 353–363 . https://doi.org/10.1038/leu.2017.222Test

    مصطلحات موضوعية: Male, Oncology, Cancer Research, Pathology, Lymphoma, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], medicine.medical_treatment, 0302 clinical medicine, International Prognostic Index, Bone Marrow, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Stage (cooking), Aged, 80 and over, Bone Marrow/drug effects, Hematology, Middle Aged, Prognosis, Diffuse, Lymphoma, Large B-Cell, Diffuse/drug therapy, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Immunotherapy/methods, Female, Rituximab, Immunotherapy, Lymphoma, Large B-Cell, Diffuse, Adolescent, Adult, Aged, Disease-Free Survival, Humans, Immunologic Factors, Young Adult, medicine.drug, medicine.medical_specialty, Article, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Internal medicine, Large B-Cell, medicine, Performance status, business.industry, medicine.disease, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Bone marrow, business, Immunologic Factors/metabolism, Diffuse large B-cell lymphoma, 030215 immunology

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65342ce8dea3970ce91b22ddf0256573Test
    https://doi.org/10.1038/leu.2017.222Test


    أضف إلى المفضلة
  7. 7
    PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration:a study from the International DLBCL Consortium Program

    المؤلفون: Thai Tran, Min Xiao, Alexandar Tzankov, Mingzhi Zhang, J. Han van Krieken, Hua You, Ken H. Young, Nathan Roscoe, Jane N. Winter, Miguel A. Piris, Hongwei Zhang, Wayne Tam, Maurilio Ponzoni, L. Jeffrey Medeiros, Xiaohong Tan, Naveen Dakappagari, Ruifang Sun, Yong Li, Karen Dybkær, Govind Bhagat, Eric D Hsi, Jooryung Huh, Lisa Adams, Yi Miao, Carlo Visco, Zijun Y. Xu-Monette, Ling Li, Ganiraju C. Manyam, Bing Xu, Andrés J M Ferreri, Michael Boe Møller, Christine Vaupel, George Z. Rassidakis

    المساهمون: Li, L., Sun, R., Miao, Y., Tran, T., Adams, L., Roscoe, N., Xu, B., Manyam, G. C., Tan, X., Zhang, H., Xiao, M., Tzankov, A., Visco, C., Dybkaer, K., Bhagat, G., Tam, W., Hsi, E. D., van Krieken, J. H., You, H., Huh, J., Ponzoni, M., Ferreri, A. J. M., Moller, M. B., Piris, M. A., Zhang, M., Winter, J. N., Medeiros, L. J., Rassidakis, G. Z., Vaupel, C. A., Li, Y., Dakappagari, N., Xu-Monette, Z. Y., Young, K. H.

    المصدر: Li, L, Sun, R, Miao, Y, Tran, T, Adams, L, Roscoe, N, Xu, B, Manyam, G C, Tan, X, Zhang, H, Xiao, M, Tzankov, A, Visco, C, Dybkaer, K, Bhagat, G, Tam, W, Hsi, E D, van Krieken, J H, You, H, Huh, J, Ponzoni, M, Ferreri, A J M, Møller, M B, Piris, M A, Zhang, M, Winter, J N, Medeiros, L J, Rassidakis, G Z, Vaupel, C A, Li, Y, Dakappagari, N, Xu-Monette, Z Y & Young, K H 2019, ' PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration : a study from the International DLBCL Consortium Program ', Modern Pathology, vol. 32, no. 6, pp. 741-754 . https://doi.org/10.1038/s41379-018-0193-5Test
    Modern Pathology, 32, 741-754
    Modern Pathology, 32, 6, pp. 741-754

    مصطلحات موضوعية: Male, 0301 basic medicine, Cell type, Pathology, medicine.medical_specialty, Programmed cell death, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], T-Lymphocytes, CD3, Programmed Cell Death 1 Receptor, Fluorescent Antibody Technique, B7-H1 Antigen, Pathology and Forensic Medicine, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Lymphocytes, Tumor-Infiltrating, 0302 clinical medicine, Biomarkers, Tumor, Tumor Microenvironment, medicine, Humans, Aged, biology, business.industry, Middle Aged, Prognosis, medicine.disease, Immune checkpoint, Lymphoma, PD1, 030104 developmental biology, 030220 oncology & carcinogenesis, biology.protein, Immunohistochemistry, Female, Rituximab, Lymphoma, Large B-Cell, Diffuse, business, Diffuse large B-cell lymphoma, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ddad34d19daa8a5e62f9c32af506ce2Test
    https://portal.findresearcher.sdu.dk/da/publications/44d07c43-0f80-46c8-9d2a-619ed60dedafTest


    أضف إلى المفضلة
  8. 8
    Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL

    المؤلفون: Hongwei Zhang, Karen Dybkær, Miguel A. Piris, Alexandar Tzankov, Jason R. Westin, Ziju Y. Xu-Monette, Jing Wang, Carlo Visco, Jane N. Winter, Maurilio Ponzoni, L. Jeffrey Medeiros, Yi Miao, Ganiraju C. Manyam, Bing Xu, Yong Li, Min Xiao, Hua You, Nicholas Hoe, Gordon J. Freeman, Raúl Torres-Ruiz, Andrés J.M. Ferreri, Wayne Tam, Ken H. Young, Qingyan Au, Govind Bhagat, George Z. Rassidakis, Xiaohong Tan, Eric D. Hsi, Sandra Rodriguez-Perales, Raghav Padmanabhan, Lan V. Pham, Michael Boe Møller, J. Han van Krieken

    المساهمون: Xu-Monette, Z. Y., Xiao, M., Au, Q., Padmanabhan, R., Xu, B., Hoe, N., Rodriguez-Perales, S., Torres-Ruiz, R., Manyam, G. C., Visco, C., Miao, Y., Tan, X., Zhang, H., Tzankov, A., Wang, J., Dybkaer, K., Tam, W., You, H., Bhagat, G., Hsi, E. D., Ponzoni, M., Ferreri, A. J. M., Moller, M. B., Piris, M. A., Han van Krieken, J., Winter, J. N., Westin, J. R., Pham, L. V., Jeffrey Medeiros, L., Rassidakis, G. Z., Li, Y., Freeman, G. J., Young, K. H.

    المصدر: Xu-Monette, Z Y, Xiao, M, Au, Q, Padmanabhan, R, Xu, B, Hoe, N, Rodríguez-Perales, S, Torres-Ruiz, R, Manyam, G C, Visco, C, Miao, Y, Tan, X, Zhang, H, Tzankov, A, Wang, J, Dybkær, K, Tam, W, You, H, Bhagat, G, Hsi, E D, Ponzoni, M, Ferreri, A J M, Møller, M B, Piris, M A, van Krieken, J H, Winter, J N, Westin, J R, Pham, L V, Medeiros, L J, Rassidakis, G Z, Li, Y, Freeman, G J & Young, K H 2019, ' Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL ', Cancer Immunology Research, vol. 7, no. 4, pp. 644-657 . https://doi.org/10.1158/2326-6066.CIR-18-0439Test
    Cancer Immunology Research, 7, 644-657
    Cancer Immunology Research, 7, 4, pp. 644-657
    Xu-Monette, Z, Xiao, M, Au, Q, Padmanabhan, R, Xu, B, Hoe, N, Rodriguez-Perales, S, Torres-Ruiz, R, Manyam, G, Visco, C, Miao, Y, Tan, X, Zhang, H, Tzankov, A, Wang, J, Dybkaer, K, Tam, W, You, H, Bhagat, G, Hsi, E D, Ponzoni, M, Ferreri, A J M, Møller, M B, Piris, M A, van Krieken, J H, Winter, J N, Westin, J R, Pham, L V, Medeiros, L J, Rassidakis, G Z, Li, Y, Freeman, G J & Young, K H 2019, ' Immune profiling and quantitative analysis decipher the clinical role of immune checkpoint expression in the tumor immune microenvironment of DLBCL ', Cancer Immunology Research, vol. 7, no. 4, pp. 644-657 . https://doi.org/10.1158/2326-6066.CIR-18-0439Test

    مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Vincristine, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], T-Lymphocytes, Programmed Cell Death 1 Receptor, Immunology, B7-H1 Antigen, CHI3L1, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Antineoplastic Agents, Immunological, 0302 clinical medicine, Immune system, immune system diseases, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Tumor Microenvironment, medicine, Humans, Neoplasm, CTLA-4 Antigen, Cyclophosphamide, CD20, biology, business.industry, Middle Aged, Prognosis, medicine.disease, Immune checkpoint, Lymphoma, Gene Expression Regulation, Neoplastic, Killer Cells, Natural, PD1, Phenotype, 030104 developmental biology, Doxorubicin, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cancer research, biology.protein, Prednisone, Lymphoma, Large B-Cell, Diffuse, Rituximab, business, CD8, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd2bda5c650a913672e02e5151bffdabTest
    http://hdl.handle.net/11562/1011409Test


    أضف إلى المفضلة
  9. 9
    Immunomodulatory drugs may overcome the negative prognostic role of active Th17 axis in follicular lymphoma: evidence from the SAKK35/10 trial

    المؤلفون: Emanuele Zucca, Alexandar Tzankov, Eva Kimby, Thomas Menter, Stefan Dirnhofer, Stefanie Hayoz

    المصدر: British journal of haematologyReferences. 190(4)

    مصطلحات موضوعية: business.industry, Gene Expression Profiling, Follicular lymphoma, CD4-CD8 Ratio, Hematology, Kaplan-Meier Estimate, medicine.disease, Prognosis, Progression-Free Survival, Neoplasm Proteins, Gene expression profiling, RAR-related orphan receptor gamma, medicine, Cancer research, Tumor Microenvironment, Humans, Immunologic Factors, Th17 Cells, business, Rituximab, Lenalidomide, Lymphoma, Follicular, medicine.drug, Randomized Controlled Trials as Topic

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed1f1998d3d4c020cb68f5b958b538daTest
    https://pubmed.ncbi.nlm.nih.gov/32525232Test


    أضف إلى المفضلة
  10. 10
    Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy

    المؤلفون: Thomas Menter, Yara Banz, Luca Mazzucchelli, Birgitta Sander, Christer Sundström, Marja-Liisa Karjalainen-Lindsberg, Sergio Cogliatti, Magnus Hultdin, Hanne Hawle, Klaus Beiske, Alexandar Tzankov, Stefanie Hayoz, Eva Kimby, Rainer Grobholz, Stefan Dirnhofer, Emanuele Zucca, Gieri Cathomas

    المصدر: British journal of haematologyReferences. 189(4)

    مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Follicular lymphoma, Immunomodulation, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Tumor Microenvironment, Humans, Lymphoma, Follicular, Lenalidomide, Aged, Aged, 80 and over, Tumor microenvironment, Hematology, business.industry, GATA3, Middle Aged, medicine.disease, Prognosis, Progression-Free Survival, 3. Good health, Lymphoma, 030220 oncology & carcinogenesis, Rituximab, Female, business, CD8, 030215 immunology, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5bd15d3a4cee078a13b9206896f5b3dTest
    https://pubmed.ncbi.nlm.nih.gov/32012230Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث